(Q35942379)

11 August 2017

An observational efficacy and safety analysis of the treatment of acute invasive aspergillosis using voriconazole (English)

1 reference

11 August 2017

0 references

invasive aspergillosis

1 reference

1 reference

A Gadisseur

5

0 references

author name string

F Jacobs

1

1 reference

11 August 2017

D Selleslag

2

1 reference

11 August 2017

M Aoun

3

1 reference

11 August 2017

A Sonet

4

1 reference

11 August 2017

language of work or name

1 reference

5 October 2011

1 reference

European Journal of Clinical Microbiology & Infectious Diseases

11 August 2017

1 reference

11 August 2017

31

1 reference

11 August 2017

6

1 reference

11 August 2017

1173-1179

1 reference

Creative Commons Attribution-NonCommercial 2.0 Generic

11 August 2017

start time

5 October 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

exact match

https://scigraph.springernature.com/pub.10.1007/s10096-011-1425-5

0 references

cites work

In vitro activity of antifungals against Zygomycetes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346940

Treatment of invasive fungal infections in cancer patients--recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346940

Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346940

Invasive aspergillosis: epidemiology, diagnosis and management in immunocompromised patients

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346940

Invasive fungal infections: a review of epidemiology and management options

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346940

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346940

Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346940

Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346940

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346940

Aspergillosis case-fatality rate: systematic review of the literature

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346940

A comparison of observational studies and randomized, controlled trials

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346940

What observational studies can offer decision makers

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346940

Management and outcome of bloodstream infections due to Candida species in England and Wales

2 October 2017

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1425-5

Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1425-5

Voriconazole Treatment for Less‐Common, Emerging, or Refractory Fungal Infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1425-5

Voriconazole treatment of invasive aspergillosis: real-world versus health-economic model results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1425-5

Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1425-5

Outcome and medical costs of patients with invasive aspergillosis and acute myelogenous leukemia-myelodysplastic syndrome treated with intensive chemotherapy: an observational study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1425-5

Clinical use and tolerability of voriconazole in the treatment of fungal infections in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1425-5

European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3--2009 update

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346940

Economic effects of aspergillosis management in high-risk patients.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346940

Recommendations for the treatment of established fungal infections

24 September 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-011-1425-5

Invasive aspergillosis in patients with solid tumors

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21971820

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Invasive Pulmonary Aspergillosis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21971820

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S10096-011-1425-5

1 reference

release_5nm4fgsyifdvpk525geuxfma6u

11 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/5nm4fgsyifdvpk525geuxfma6u

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

11 August 2017

PubMed publication ID

21971820

1 reference